For an efficient distribution of drugs and drug carriers through biological barriers such as the vascular system, the size and surface properties of nanoparticles and molecules play a key role.
Introduction
In the human body, complex biological barriers prevent the entrance and distribution of pathogens and other foreign compounds. In addition to their protective function, those barriers also regulate the passage of the beneficial molecules such as nutrients, growth factors, proteins, hormones or polysaccharides [1] [2] [3] . Examples for such complex biological barriers in the human body include the blood-brain-barrier [4] , the skin [5] , the gastrointestinal tract [6] , the oral cavity [7] and the vascular system [8] . All these examples share a common structure: they consist either of endothelial cells (blood-brain barrier and vascular system) or epithelial cells (oral cavity, skin and gastrointestinal tract) which are coated by a biopolymer matrix. This extracellular matrix (ECM) can be located on the outer side of the cell layer where it constitutes the first line of defense against pathogens as in the oral cavity or the gastrointestinal tract [9] . Alternatively, the ECM may also be located on the basolateral side of the cell layer as it is the case for the basal lamina surrounding blood vessels. Here, the passage of molecules and cells from the blood stream into the adjoining tissue is primarily regulated by the endothelial cells. However, compared to physiologic conditions, the ECM layer becomes more accessible for molecules when the endothelium becomes leaky e.g. during inflammation, infection, or in the presence of a tumor [10, 11] . Moreover, macromolecules which are bi-directionally exchanged between the blood stream and the interstitium by transcytosis, a mechanism particularly prominent in vascular endothelial cells [12] , need to pass the basal lamina. Similarly, if molecules from the connective tissue are supposed to enter into the blood stream, e.g. in the case of subcutaneous injection of heparin or insulin, they need to cross the basal lamina from the basolateral side of the blood vessel wall. In those cases, the basal lamina acts as the primary barrier.
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Advanced drug delivery methods make use of the leaky endothelium for the specific targeting of tumors [13] . The efficiency of drug carriers to pass the endothelium and the ECM barrier can depend on several parameters e.g. particle size, shape and surface modification. Experiments conducted in bulk systems showed that ECM gels show a high selectivity for nanoparticles based on their charge and hydrophobicity [14, 15] . However, the diffusive entry of particles into the ECM at the interface between the basal lamina and a liquid phase (such as the blood stream) cannot be characterized in those bulk experiments. In addition to the diffusion behavior of nanoparticles also the spreading of encapsulated drug molecules, once they are released, is of great interest [16] . To investigate both, two approaches are possible: in vivo experiments in mammals such as mice, rats, rabbits or in vitro testing in an appropriate tissue-on-a-chip setup. A pre-screening for important parameters in a robust in vitro setup which reliably predicts the diffusive spreading of pharmaceuticals in vivo would be highly desirable since it would reduce the need of animal tests [17] .
One promising approach for the realization of such predictive in vitro experiments is microfluidics [18, 19] . There are already a broad range of experimental settings in which such an approach is used, e.g. for the design of a cardiac tissue model [20] , for the investigation of nanoparticle translocation across a permeable endothelium [21] or through a endothelial/epithelial double layer simulating the biological interface in alveoli [22] . Those chips are able to reproduce key results obtained in living tissue in an in vitro setting although their setup is strongly simplified: to date, most of those microfluidic penetration assays mainly focus on the barrier function of the cell layer and neglect the influence of the adjacent biopolymer matrix. This is partly due to the fact that it is technically challenging to deposit a soft biopolymer gel on a microfluidics chip in such a way that a stable gel/liquid interface is generated which can
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Here, we present a microfluidic assay for the quantification of the diffusive transport of molecules across basal lamina interfaces. As a model system for the basal lamina, we use an extracellular matrix gel which has been purified from the Engelbreth-Holm-Swarm sarcoma of mice. We compare the penetration efficiency of different fluorescent molecules such as dextrans with different molecular weights and net charges as well as customized peptides. In our microfluidics setup, those molecules accumulate at the gel/buffer interface in a charge selective manner in full agreement with model calculations considering transient binding of molecules to the gel components. In vivo microinjection experiments conducted in mice show a similar charge selective accumulation of those molecules around blood vessels and a colocalization with collagen IV, a key component of the basal lamina. Thus, our in vitro setup successfully predicts the selective transport of molecules across this biological barrier.
Results and Discussion

Generating a stable gel/liquid interface on chip
To study the diffusion of different solutes across an extracellular matrix gel we first design a microfluidic chip which allows us to generate a stable gel/liquid interface. As shown in Figure 1 (for more details see Figure S1 ), this chip has one outlet and two inlets, one for inserting the ECM and one for inserting buffer with fluorescent solutes. Liquid (i.e. ice-cold) ECM is filled into the chip through inlet 1. Here, at half the channel length, a "finger-like" structure begins where five pillars divide the main channel into six smaller channels of identical width. 
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When liquid ECM is filled into inlet 1, it can be carefully pushed into this finger-like structure until, at the end of the pillars, surface tension effects ensure stopping of the liquid (see inset of Figure 1 ) and prevent it from entering into the buffer channel which is oriented perpendicular to the pillars. With this setup, a well-defined liquid/air interface is created which is important for the following experiments. As the ECM is inserted into the chip in its liquid state, gelation has to be induced on chip. Such a gelation of ECM is usually achieved by a heating step to 37 °C for 30 minutes (see Methods). However, we here induce gelation at room temperature since all following experiments are conducted at this temperature. During gel formation, it is important to prevent drying of the ECM -especially at the interface to the compartment which will be filled with fluorescent solutes. A naive approach to avoid such drying of the ECM interface might be to induce gel formation at a water interface. This could be achieved by inserting an aqueous solution, e.g. buffer, through inlet 2 directly after loading the chip with the liquid ECM.
However, as gelation requires some time, the mechanical strength of the ECM is still weak when the buffer is inserted, and thus the integrity of the ECM compartment is disturbed by buffer influx. Furthermore, when placed at an aqueous interface during gelation, the ECM tends to swell and locally dissolves which in turn results in a diffuse gel interface. A better solution would be to perform gelation at an interface with a hydrophobic fluid that is immiscible with the ECM (and thus does not dissolve the ECM matrix) but still prevents drying. We chose a polydimethylsiloxane oil (PDMS) which fulfills those requirements and is based on the same polymer used for crafting the microfluidic chip. We insert the PDMS oil through inlet 2 into the lower channel and keep it in this compartment until ECM gelation is finished. The oil is then removed from the chip through the outlet and replaced by PBS buffer which is inserted through inlet 2. When the PBS is inserted into the channel, a clear interface between PBS and PDMS oil 8 is visible under the microscope. This feature allowed us to monitor the proper removal of the oil from the channel. With this approach, we are able to generate intact gel/buffer interfaces with which we obtain reproducible penetration profiles with different test molecules.
DEAE-dextrans accumulate at the ECM/buffer interface
We first investigate the correlation between the diffusion efficiency of molecules across an ECM interface and their net charge. We use two variants of FITC-labeled dextrans with a molecular weight of 150 kDa, and those dextrans carry a certain percentage of either diethylaminoethyl (DEAE) or carboxymethyl groups (CM). For the experiments, both sorts of dextrans are dissolved in PBS at a concentration of 10 mg/mL. Since the pH of the solution is neutral, the DEAE groups are protonated and therefore positively charged, whereas the CM groups are deprotonated and thus negatively charged (see also Table 1 [14, 15, 25] . However, it is important to recall that ECM gels immobilize positively charged particles more efficiently than negatively charged ones -a behavior which was suggested to arise from the high concentration of negatively charged heparan sulfate in ECM gels [14] . The higher tolerance of the ECM gel for negatively charged nanoparticles could also explain why DEAE-dextrans, which have a net charge of +200e, and CM-dextrans with a net charge of -165e show a different behavior at the gel/buffer interface.
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(which is in the µm range [14] ), molecule-polymer interactions will be rare both in the bulk volume of the ECM as well as at the ECM/buffer interface. However, we speculate that the high concentration of dextran molecules in the buffer compartment balances the rareness of the binding events giving rise to the observed accumulation of molecules at the gel/liquid interface.
To test this hypothesis, we model the diffusive entry of molecules into a gel compartment. For this model, we make the following assumptions: in the buffer compartment the DEAE-dextrans are present at high concentrations and diffuse freely. However, as soon as they reach the buffer/ECM interface they can transiently bind to the ECM network which temporarily interrupts Lab on a Chip Accepted Manuscript accumulate at the interface whereas negatively charged dextrans do not. Also, the height of the accumulation peak seems to be similar for both DEAE-dextran variants.
kDa DEAE-dextrans accumulate around blood vessels in murine tissue
Of course, in our microfluidic assay many simplifications had to be introduced compared to the in vivo situation we aim to mimic. Thus, we next test whether a similar charge-dependent accumulation of dextrans also occurs in living tissue. For this purpose, we perform experiments in living mice and deposit differently sized and charged FITC-labeled dextrans into the mouse cremaster muscle by microinjection. As injection sites, we choose locations in close proximity to blood vessels (i.e. postcapillary venules). The venular basement membrane maintains the integrity of the blood vessel and, due to the dense network of matrix proteins, it constitutes a barrier for diffusing macromolecules and emigrating leukocytes [28] .
First, the distribution of injected 150 kDa DEAE-dextrans is investigated. From our in vitro experiments, we expect that those dextrans accumulate at the basolateral side of blood vessels where endothelial cells secrete basal lamina components. Indeed, within 5 min after microinjection ( Figure S3) we observe a pronounced accumulation of 150 kDa DEAE-dextrans around nearby blood vessels, and this accumulation remains stable during the whole observation time of 60 min (Figure 2 E, white arrows) . If this accumulation is also charge selective in vivo, then the CM-dextrans should exhibit a different behavior. Indeed, in contrast to the DEAEdextrans, the CM-dextrans do not accumulate around blood vessels within the observation time of 60 min (Figure 2 D) . They do, however, seem to concentrate in muscle fibers close to the injection site. We assume that, if the muscle is pierced by the glass capillary during microinjection, a fraction of the 150 kDa CM-dextrans is brought in direct contact with this Figure S4 ).
The net charge of a molecule sets its accumulation propensity
It was suggested previously that the surface properties of diffusing particles and molecules, e.g. their net charge, might play a key role in determining their immobilization efficiency in extracellular matrices [14, 29, 30] . Polystyrene particles and liposomes trapped in the bulk volume of ECM gels possess a net charge of up to ±10 10 e and ±10 5 e, respectively. In contrast, the net charge is only +200e for the 150 kDa DEAE-dextrans and -165e for the 150 kDa CM-dextrans and +5e and -4e, respectively, for the 4 kDa dextran variants ( Table 1) . A direct comparison of nanoparticles and molecules is, of course, difficult. However, also comparing dextrans of different molecular weight is not trivial as those molecules carry different amounts of fluorophores in addition to their DEAE and CM functionalization.
To investigate the influence of the net charge of a molecule on its diffusion across ECM interfaces, we switch from dextran molecules to customized peptides. These synthetic peptides all have the same length, i.e. 24 amino acids, and carry one TAMRA label at the N-terminus. We compare the diffusion of four different amino acid sequences, which were designed to differ in terms of their net charge but have similar molecular weights: (KKK) 8 (KKK) 8 and (QQK) 8 accumulate both at the gel/buffer interface, yet the intensity of this accumulation peak is higher for (KKK) 8 than for (QQK) 8 . However, the distribution profile of those peptides within the gel region is comparable to the negatively charged peptides. In contrast to the dextrans, the accumulation propensity of the two positively charged peptide variants can now directly be compared. We measure an accumulation peak intensity of 105 % for (QQK) 8 and 133 % for (KKK) 8 , respectively, compared to the fluorescent intensity of the peptides in the buffer compartment. It is reasonable to assume that the binding affinity of the strongly charged (KKK) 8 peptide to the ECM gel is larger than for the weakly charged (QQK) 8 peptide. Indeed, reducing the binding affinity in our model by an order of magnitude reproduces the decrease in the height of the accumulation peak observed in our in vitro experiments (Figure 3 A) .
Charged molecules accumulate at the basolateral side of blood vessel walls
To better specify which subsection of the tissue is responsible for the charge selective accumulation of molecules, we repeat the microinjection with the different peptide variants and perform a colocalization test with key components from blood vessels. Already 5 min postinjection, negatively charged (EEE) 8 peptides spread from the injection site into the surrounding connective tissue and, after 60 min, a spatially homogeneous fluorescence signal is obtained (Figure 3 E) . In contrast, when the (KKK) 8 
Experimental section
Microfluidic channel
Soft lithography was used to fabricate the microfluidic chips. The channel geometry was designed using AutoCAD (Autodesk, Munich, Germany) and the mask was printed at a resolution of 64000 dpi (Zitzmann, Eching, Germany). The master was fabricated on a silicon wafer (Siegert Wafer, Aachen, Germany) with EpoCore (micro resist technology, Berlin, Germany) as a negative photoresist. After spin coating (Laurell, North Wales, USA) onto the silicon wafer for 35 s at 1000 rpm two prebake steps were conducted: first at 65 °C for 5 min, second at 95 °C for 10 min. After cooling down, the photoresist was exposed to UV light for 7 min to ensure cross-linking. Post-exposure baking were conducted at 65 °C for 5 min and subsequently at 95 °C for 20 min. The wafer was developed using mr-Dev 600 (micro resist technology, Berlin, Germany) to remove all remaining uncrosslinked photoresist. Finally, the master was rinsed with isopropanol to remove remaining developer. For the microfluidic channel fabrication Sylgard 184 (Dow Corning, Midland, MI, USA) elastomer was mixed at a 10:1 ratio with curing agent, degassed for 30 min, poured onto the master and cured at 80 °C for 1 h. The cured PDMS was peeled off and bonded to a glass slide using oxygen plasma at 20 W for 30 s.
The bonded device was stored in an oven at 120 °C overnight to regain its hydrophobic properties.
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ECM, Dextrans and Polypeptides
Growth factor reduced extracellular matrix gel (ECM) with a protein concentration of 7.37 mg/mL purified from the Engelbreth-Holm-Swarm sarcoma of mice was obtained from Sigma-Aldrich. For experiments, ECM was thawed on ice for several hours and afterwards a volume of 2 µL was inserted into the microfluidic device through inlet 1. Here, E represents glutamic acid, K denotes lysine and Q denotes glutamine (according to the 1-letter amino acid coding). Glutamic acid has a molecular weight of 147.13 g/mol, and the free side-chain carboxylic acid group of this amino acid has a pK a of 4.1. This results in a negatively charged group at physiological pH which is used in our experiments. Lysine has a molecular weight of 146.19 g/mol, and the pK a of the side chain amino group is 10.5; as a consequence, this amino acid is positively charged at neutral pH. Glutamine has a molecular weight of 146.15
g/mol and a zwitterionic side chain. Glutamine therefore assumed to be net neutral at pH 7. For the experiments, the peptides were dissolved in PBS and used at a concentration of 1 mg/mL.
Buffer containing test molecules was carefully inserted into inlet 2 with a Hamilton syringe (1702 sleeve type), which ejects a volume of 0.33 µL per rotation. When the channel was completely filled with buffer the flow was stopped to match the in vivo situation where the test molecules are injected into the connective tissue. Thus, after a short time of equilibration no flow of test molecules is present. Germany) microscope using a 4x objective (Zeiss, Oberkochen, Germany). The exposure time was chosen such that no pixel saturation occurred. Each of the six channels was analyzed individually with ImageJ. A rectangle with a height of 880 pixels corresponding to 2.75 mm and a width of 30 pixels (0.09 mm) was placed in the channel such that 50 (0.16 mm) pixels of this rectangle were located in the lower channel (Figure 1 B) . This procedure allows us to account for the bleaching of the fluorescent label of the test molecules. Since no continuous flow was applied, the fluorophores in the buffer compartment are subjected to same rate of bleaching as the molecules within the ECM. Therefore, the fluorescence intensity in the buffer channel (calculated from the 50 pixels of the rectangle in the lower channel) was used as a reference to normalize the intensity in the finger-like structure. This ensures the comparability of the calculated intensity profiles at different time points during the experiments.
The intensity within the chosen rectangle was averaged per pixel line with a function implemented in ImageJ. Thus, one intensity value per line was obtained. In a next step, these average intensity values per line were averaged again, first over the six finger channels of a chip and then over three different microfluidic chips.
Animals and surgical procedure
Male C57BL/6 mice at the age of 10-12 weeks were purchased from Charles River (Sulzfeld, Germany). Animals were housed under conventional conditions with free access to food and water. All experiments were performed according to German legislation for the protection of animals. The surgical preparation was performed as described by Baez [31] with minor modifications. Briefly, mice were anesthetized by intraperitoneal injection of a ketamine/xylazine mixture (100 mg/kg ketamine and 10 mg/kg xylazine). The right cremaster muscle was exposed through a ventral incision of the scrotum. The muscle was opened ventrally in a relatively avascular zone, using careful electrocautery to stop any bleeding, and spread over the pedestal of a custom-made microscopy stage. Epididymis and testicle were detached from the cremaster muscle and placed into the abdominal cavity. Throughout the procedure as well as after surgical preparation during in vivo microscopy, the muscle was superfused with warm buffered saline. The body temperature was maintained at 37 °C using a heating pad placed under the mouse. After in vivo microscopy, tissue samples of the cremaster muscle were prepared for immunohistochemistry. Anaesthetized animals were then euthanized by an intra-arterial pentobarbital overdose (Narcoren, Merial, Hallbergmoos, Germany).
In vivo microscopy
The setup for in vivo microscopy was centered around an VisiScope.A1 imaging system 
Microinjection of dextran and peptides
Local administration of 250 +/-100 pL of fluorescently labeled dextran (2 mg/mL) or peptides
(1 mg/mL) into the cremaster muscle was performed via perivenular microinjection in regions at a distance of 25 to 50 µm from a postcapillary venule [32] . Venules with diameters ranging between 25 and 35 µm were selected for the experiments. Microinjection was performed under visual control of the intravital microscope, with a long distance air objective (20 x, NA 0.4
Olympus), using borosilicate glass micropipettes (GB150TF-8P, Science Products GmbH, Hofheim, Germany) -pulled with a micropipette puller (PC 10, Narishige, London, United Kingdom) -which were connected to the injection system consisting of a micromanipulator (PatchStar Micromanipulator, Scientifica, Uckfield, United Kingdom) and a microinjector (FemtoJet, Eppendorf, Hamburg, Germany). The tip pressure during injection was 3000 hPa and the tip diameter < 1 µm. The vessel and the surrounding tissue were visualized during a time period from 1min to 60 min after injection.
Mice (n=3 each group) received 150 kDa CM-dextran, 150 kDa DEAE-dextran, (KKK) 8 peptides and (EEE) 8 peptides via microinjection 20 min after the preparation of the cremaster muscle. The animals were randomly assigned to the experimental groups.
Immunostaining
To determine the charge dependent localization of peptides, immunostaining of the cremaster muscle was performed. After dissection, the tissue was fixed with 2 % paraformaldehyde for
